Latest News

Findings point toward one of first therapies for Lou Gehrig's disease

Researchers have determined that a copper compound known for decades may form the basis for a therapy for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. In humans, prior to this, no therapy for ALS has ever been discovered that could extend lifespan more than a few additional months.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • BPA exposure linked to autism spectrum disorder, study reports

  • BPA exposure linked to autism spectrum disorder

  • One step closer to defeating Alzheimer's disease

  • Cerebral blood flow as a possible marker for concussion outcomes

  • Survey of teen dating violence among US high school students

  • Minors easily able to purchase electronic cigarettes online

  • Scientists crack piece of neural code for learning, memory

  • Low sugar uptake in brain appears to exacerbate Alzheimer's disease

  • New assessment tool can predict successful teachers

  • Heart valve repair significantly improves emotional wellbeing in patients with mitral regurgitation

  •